Bio-Works Technologies AB (publ)

DB:1BD Stock Report

Market Cap: €8.4m

Bio-Works Technologies Balance Sheet Health

Financial Health criteria checks 4/6

Bio-Works Technologies has a total shareholder equity of SEK44.0M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK62.2M and SEK18.1M respectively.

Key information

0%

Debt to equity ratio

SEK 0

Debt

Interest coverage ration/a
CashSEK 39.38m
EquitySEK 44.03m
Total liabilitiesSEK 18.12m
Total assetsSEK 62.15m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 1BD's short term assets (SEK59.7M) exceed its short term liabilities (SEK18.1M).

Long Term Liabilities: 1BD has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: 1BD is debt free.

Reducing Debt: 1BD has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 1BD has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: 1BD has less than a year of cash runway if free cash flow continues to reduce at historical rates of 1.9% each year


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.